39 results
20-F/A
2023 FY
BLRX
Bioline Rx Ltd
26 Mar 24
Annual report (foreign) (amended)
4:57pm
to patients;
physicians and patients may stop using our product; and
our reputation may suffer.
Any of these events could harm our business … constraints of the third parties;
impact on our reputation in the marketplace if manufacturers of our products, once commercialized, fail to meet customer
6-K
EX-99
BLRX
Bioline Rx Ltd
16 Dec 20
Current report (foreign)
8:00am
at Sheba’s Pancreatic Cancer Center. She has earned a world-renowned reputation for her studies in the field of pancreatic cancer. Her current research
20-F/A
kwevtnz
23 Mar 15
Annual report (foreign) (amended)
12:00am
424B5
sbg42wpwtm0dpu
6 Mar 15
Prospectus supplement for primary offering
12:00am
424B5
dk8xu65yhsj0 khm
5 Mar 15
Prospectus supplement for primary offering
12:00am
6-K
EX-99.3
ciydp qlx9or6nkmc19
5 Mar 15
Current report (foreign)
12:00am
424B2
7ekdji4
13 Jun 14
Prospectus for primary offering
12:00am